September 16-18, 2025
Hynes Convention CenterBoston, MAKey Sessions
Matthew Klinker
Keynote Presentation: Navigating Regulatory Frameworks for Cell and Gene Therapies
CBER, FDA
Anthony Davies
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
Dark Horse Consulting Group Inc.
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
keyboard_arrow_leftSearch & Filter
search
Streams
Clear
Tuesday 16th September, 2025 - Workshop & Keynotes - ET (Eastern Time, GMT-05:00)
search
Streams
Clear
Showing 1 of 1 Streams
Keynote Plenary
2:00pm - 2:05pm
Welcome to Cell and Gene Therapy International and Chairperson’s Opening Remarks
2:05pm - 2:50pm
Keynote Panel Discussion: Big Pharma’s CGT Playbook - Top Investment Priorities and Emerging Opportunities
- Anthony Davies - Founder & CEO, Dark Horse Consulting Group Inc.
- Wolfram Carius - EVP Pharmaceuticals, Bayer
- Erin Kimbrel - Head of Cell and Gene Research, Astellas Pharma Inc.
- Stephen Kennedy - Head of Technical Operations, CRISPR Therapeutics
- Ruth Salmon - VP, BMS Cell Therapy Research, Bristol Myers Squibb
2:50pm - 3:30pm
Investor Panel Discussion: Investments in Cell and Gene Therapies and Enabling Technologies
- Bryan Poltilove - Strategic Advisor and Independent Board Director, Independent
- Daniel Friedman - Principal, BroadOak Capital
- Aaron Fisher - Director, Life Sciences Investments, ARCHIMED
- Fiona Miller - Managing Partner, quadraScope Ventures
- Mary Schaheen - President and Director, Prevail Partners
Showing 1 of 1 Streams
Keynote Plenary
4:30pm - 5:10pm
Keynote Presentation: Navigating Regulatory Frameworks for Cell and Gene Therapies
- Matthew Klinker - Branch Chief - Cell Therapy Branch 2, CBER, FDA
Filter
Streams
Clear